Broker Hotline 1-888-776-6565
More Information [email protected]

News

Final DOL Fiduciary Rule Applies to HSA Plan Advisors

Last Friday, the Department of Labor released its highly anticipated final version of the fiduciary rule that includes a significant expansion of those who will fall under the definition of a fiduciary. The rule will now apply to advisors who offer advice on health savings accounts (HSAs). HISTORY In 2010, the DOL began to develop… Read More

CMS April 7, 2016 Webinar MARKETPLACE 101

CMS National Training Program Marketplace 101 Webinar April 7, 2016 1:00 – 2:30 pm ET This webinar provides a high-level overview of the Affordable Care Act and the Health Insurance Marketplace, including information on coverage, tax credits, and fees. To register for the free webinar visit https://goto.webcasts.com/starthere.jsp?ei=1093375  

Obamacare & your Taxes – Reminders on What’s New this Year

This year marks the second year that your health insurance choices could have an impact on your taxes. Here are some things to keep in mind when preparing to file your 2015 taxes: You will receive Tax form 1095-B or 1095-C from your employer, an insurance company (if you have an individual plan), or from… Read More

Healthcare.gov to add Network-Breadth Ratings

Starting in 2017, consumers will be able to obtain information on network breadth ratings when comparing health care plans. This rating will show the number of doctors, hospitals, and specialists, within each network to help consumers can make informed decisions when choosing the best health plan for their needs. The third annual health care open-enrollment… Read More

CMS to Allow States to Monitor Adequacy of Health Plan Network

The Centers for Medicare & Medicaid took a step back from their proposed strict federal level regulation of the adequacy of health plan networks and instead will allow states the time to adopt a proposal from the National Association of Insurance Commissioners. The NAIC proposal addresses the issue over narrowing network plans that are particularly of concern… Read More

Why U.S. Drug Costs Are Out of Control

In his New York Times article “New Dosages of Old Drugs are used to Raise Their Prices,” Barry Meier addresses the controversial trend in the drug industry in which newly manufactured dosages of common drugs are being introduced into the marketplace to circumvent cost controls. The ulterior motive? Egregious markups, whose resulting profits end up… Read More